Format

Send to

Choose Destination
See comment in PubMed Commons below
J Cutan Pathol. 2011 Apr;38(4):346-50. doi: 10.1111/j.1600-0560.2010.01592.x. Epub 2010 Aug 18.

Lupus erythematosus-like imiquimod reaction: a diagnostic pitfall.

Author information

  • 1Department of Dermatology and Pathology, University of California Davis Medical Center, Sacramento, CA, USA. keirabarr@yahoo.com

Abstract

Imiquimod (AldaraTM), a Toll-like receptor 7 agonist (TLR7), is known for its unique properties of being an immune response modifier and stimulator. Upon topical application, this TLR7 agonist triggers a cell-mediated immune response predominantly expressed by dendritic cells and monocytes. Local skin irritation at the application site involving erythema, pain, crusting and erosions is common and well documented. On the contrary, the specific histopathologic features associated with these treatment site reactions is not. Herein reported is a case where historical omission of imiquimod use for actinic keratosis complicated the histologic interpretation. We highlight a lupus erythematosus-like microscopic pattern and explore histopathologic features that could help in avoiding a diagnostic pitfall, as well as the relationship between TLR activation, cell-mediated immunity and skin histology.

Copyright © 2010 John Wiley & Sons A/S.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Write to the Help Desk